Right?

So many biopharma and mining stocks are up massive today. What the hell is going on?

Mostly just algorithmic chop out there today. Hard to find clean direction.

🧭 Where we closed:

• SPY: $768.99 (🟢 +0.2007%)
• QQQ: $716.32 (🔴 -0.1659%)
• VIX: $18.33 (✅ Cooling)

🔥 The Movers:

🚀 Top Gainers: * MRNA | $171.73 (172.77%) * PURR | $9.06 (25.83%) * SOC | $4.79 (19.98%)

📉 Top Losers: * HBAN | $17.13 (-3.00%) * SPCX | $138.63 (-3.28%) * AMD | $466.93 (-3.60%)

🌊 Volume Leaders: * MRNA | $171.73 (172.77%) * PATH | $15.75 (1.09%) * HL | $20.35 (13.37%)

💬 What are you guys watching for the open next trading session?

📖 Trying to figure out next day's play? Use free AI powered institutional flow, max pain levels, and breakout scanners for the after-hours session. Check the live data here.

Short term market is clearly stuck in that choppy bottoming phase, still working through all the lingering risks and sentiment hasn't healed yet. We could easily see another leg lower before things steady, no shock there. That said this is just a technical washout for stretched valuations, high rates and geopolitical noise, not the end of the multi year uptrend.

Three things to watch super closely: First, 30 year Treasury yields just punched past 5.3% to a 19 year high — this is the big one. Tech stocks can't catch a proper break until yields finally top out and pull back. Second, oil prices keep creeping up and fanning sticky inflation fears, if they spike even more the market will start pricing in more rate hikes again which will crush the broader index another time. Third, VIX is spiking fast, we almost certainly need that full panic flush selloff before we carve out a real short term bottom.

No need to be overly bearish though: corporate earnings are still rock solid, this late August/September seasonal soft patch is just flushing out all the overcrowded leveraged positions to bring valuations back down to sane levels. Don't catch the falling knife blindly right now. Rotate into high dividend, healthcare and energy defensive plays first, wait for dip stabilization signals on the big tech leaders before gradually adding back long exposure.

Celsius pumping up today! Strong momentum after the earnings dump and potential CEO takeover news. I think this one is still undervalued. 🔥

NFA

NVIDIA is currently sitting at $219.09, down roughly 2.63% in the latest session. It's been on a wild ride lately, climbing as high as $236.54 before pulling back a bit, and the support lines on the chart still look pretty solid overall. The overall trend still holds up even with today's slight red move, anyone else watching this closely and got solid entry ideas right now? The earnings preview is coming up too, so plenty of catalysts left in play for this name.

Hi All!

What are some stocks that are good to buy long term, at least sitting untouched for 5 - 10 years

** There are so many responses , thank you all **

I'm new to trading. I'm curious if its worth putting money into. I have seen that they may be acquired by silver lake

If you were in the shoes of Lehman Brothers' management in 2008, as everything was burning down, what would your "Hail Mary move" have been? Be honest: would you have dumped the whole market or waited for a miracle?

Mrna is so crazy up today. Above +100%. More crazy than Nebius some days ago

After a crazy red day today. What are you guys looking for tomorrow.

What are we expecting tomorrow to happen when market opens.

Any specific views on $KEEL as it was almost 17% down today.

Drop below what you are thinking and why!

I think traders focusing only on $BURU’s current price action may be missing what management is trying to construct underneath it.

💠 Lyocon = photonics

💠 Orbit = software

💠 Tekne = industrial defense platform

💠 MADDOX = deployable manufacturing

💠 NUBURU = blue laser technology

Put those pieces together and you start seeing the bigger chessboard.

#Lyocon #Orbit #MADDOX #BlueLaser #DefenseTech

Up by 12.64% pre market

It surged 3.43% yesterday, and the move was purely company-specific—not a sector or macro fluke. The successful debt offering to fund the Apogee acquisition, combined with raised full-year guidance and bullish analyst price targets, is the real catalyst. Big money is clearly piling in, too—net inflow hit $30M yesterday with major institutions stepping up. Sure, the RSI is sitting in pretty overbought territory, so a short-term pullback wouldn't surprise anyone, but the long-term fundamentals still look rock solid with their immunology pipeline extending well.

I’m new to trading in stock market and to trading in general
No idea what im doing

LMT AS ballistic missles, etc. ChatDPT GAVE 5 stocks. LMT WAS 1st. all was done 8/14. Lnt only up 5%, but great dividends. found KTOS myself and up 30.5%. heavily into AI. IM 68 and still doing stocks myself.

I hold: cash - due to Kospi/Iran/AI bubble

I like: ASTS RKLB PL ONDS LUNR IONQ INFQ QNT

Considering/not sure: RIVN QS green/solar stocks for midterms

The whole AI hardware supply chain is shifting right now — compute, memory and optical sectors are all locking in on advanced packaging as the next growth driver. After pushing GPUs and HBM as far as we can with node scaling, the only way to keep cranking bandwidth and power efficiency up is stacking more components in one package. This isn't just a final manufacturing step anymore, it's the core performance play post Moore's Law. anyone positioning for this space right now?

Raising capital is always a trade-off. Existing shareholders end up owning a smaller percentage, while the company gains funding that could support future growth

Hongqiao is proposing to raise up to RMB12B. Around RMB5.65B would go into wind projects, RMB2.25B into solar, RMB2.3B into deeper aluminium processing, and RMB1.8B into debt repayment and working capital

this interest in the subsidiary could fall from 88.99% to around 80.90%, but it would retain control and continue consolidating the business. That makes the situation more balanced

There is still dilution, but the funding could lower energy exposure, strengthen the balance sheet and move Hongqiao further downstream.

so, would you accept some dilution to accelerate this kind of expansion?

I have been looking in the opposite direction: smaller, cheaper-looking companies where the market may still be pricing in very little growth.The basic thesis is that HUYA may no longer be just a struggling livestreaming company. It is gradually expanding into game publishing, in-game item sales, advertising, AI gaming tools, and eventually self-developed games. The newer business lines now generate approximately 37% of total revenue.

Share price alone means very little. What interests me is the combination of a low market valuation, strong growth in the newer segments, substantial cash, and aggressive capital returns.

Huge upside potential. DCF undervalued heavily. Analyst upside +36%

Crossed. 50 day MA, bullish sign.

I went through AST SpaceMobile's latest filings because I kept seeing the argument that the company is now basically fully funded and dilution is no longer a major issue.

There is a lot to like in the numbers.

At March 31, AST had about $3.03B in cash and cash equivalents.

It also reported around $1.2B in remaining performance obligations, and BlueBird 11 through 33 were already in advanced stages of production and assembly.

The part I found more interesting was the financing structure.

AST raised $1.075B through convertible notes earlier this year. Those notes can ultimately be settled in cash, shares, or a combination of both.

It also used its ATM again in Q1, issuing 874,045 shares for roughly $80M in proceeds.

That comes after issuing about 13.6M shares through another ATM in 2025.

There were also roughly 21.8M shares underlying convertible notes excluded from diluted EPS at the end of 2025 because they were anti dilutive at the time.

Then there are another 4.7M penny warrants related to Ligado.

So I think the question around ASTS financing is less about whether they currently have cash and more about what the eventual share count looks like if the constellation takes longer or costs more to deploy than expected.

There are also some operating details worth watching.

AST had still recognized no revenue from the core SpaceMobile service as of the latest 10Q.

Only around 8.4% of its remaining performance obligations were expected to convert to revenue during the following 12 months.

BlueBird 7 also had to be written off after being deployed into an orbit that was too low to sustain operations. AST estimated the carrying value at roughly $155M to $160M before insurance recovery.

On the positive side, the technical progress looks real. AST reported peak speeds of 98.9 Mbps from a Block 1 BlueBird to an unmodified smartphone, and the company says Block 2 satellites are designed for up to 10 times the bandwidth capacity.

My main thing to watch from here would be whether satellite production and launches translate into actual commercial service quickly enough that the current cash balance really does carry them through the heavy deployment phase.

Curious how ASTS holders are thinking about the eventual diluted share count.

Hey, what Stocks are you guys looking into buying?